The Safelia® autoinjector developed by Nemera wins the ‘Patient Centricity & Customization’ Innovation Award at Pharmapack


A team of industry experts rewards Nemera’s autoinjector with a Pharmapack Award as best innovative product.

On February 1st, during the Award ceremony at Pharmapack, Safelia®, Nemera’s innovative autoinjector, was celebrated as a best in class innovation displayed at the show for “Patient Centricity & Customization”.

Safelia® is an innovative autoinjector for prefilled syringes, available for 1 and 2.25 ml sizes, suitable for large volume and high viscosity delivery through thinner needles. Safelia® can mechanically “tune” the injection thanks to design adjustments.

It has been designed to ease patients’ self-injection experience and to deliver the most challenging drugs, in subcutaneous or intramuscular layers.


Key benefits of Safelia®

Patient friendly

  • No initial injection peak
  • Constant delivery flow
  • Adjustable needle insertion speed
  • Needle insertion disconnected from injection
  • Automatic needle retraction
  • Possibility to have thinner needles

Syringe friendly

  • Syringe is held encapsulated through the barrel
  • Syringe front housing
  • No stress on the syringe flange
  • Possibility to inject very viscous drugs

Safelia-Pharmapack Award winner

Safelia® will also be shown at next events we will attend:

  • DDP, February 7-9, Palm Beach Gardens, FL, US
  • INTERPHEX, March 8-10, New York, NY, US
  • SMI PFS East Coast, April 26-27, Boston, MA, US
  • FCE Pharma, May 23-25, Sao Paulo, Brazil
  • SMI PFS West Coast, June 6-7, San Diego, CA, US
  • CPhI China, June 20-22, Shanghai, China
  • CPhI WorldWide, October 24-26, Frankfurt, Germany
  • PDA Prefilled syringes and Injection devices, November 7-8, Vienna, Austria
  • CPhI India, November 28-30, Bombay, India

A Pharmapack Exhibitor Award recognizes the product excellence in each criterion (role for health improvement, economical interest, user consideration and quality of pitch), a competitive differentiator, and clearly reflects excellence in pharma and biopharma development and manufacturing.

Attached documents:

About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery solutions. Its expertise covers all five modes of delivery: parenteral (autoinjectors, pens, safety devices & implanters), ophthalmic (multidose, preservative-free eyedroppers), nasal, buccal, auricular (pumps, valves and actuators for sprays), pulmonary (pMDIs, DPIs), dermal and transdermal (airless & atmospheric dispensers).
Nemera provides solutions for the pharmaceutical, biotechnology & generics industries, from full solution development to pure contract manufacturing, through customized solutions.